(Q71842354)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7599759%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

ACE inhibition preserves renal function better than beta-blockade in the treatment of essential hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7599759%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

ACE Inhibition Preserves Renal Function Better thanbT-blockade in the Treatment of Essential Hypertension (English)

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

5 June 2024

main subject

essential hypertension

1 reference

A. Himmelmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7599759

5 June 2024

L. Hansson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7599759

5 June 2024

B. G. Hansson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7599759

5 June 2024

H. Hedstrand

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7599759

5 June 2024

K. Skogström

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7599759

5 June 2024

J. Ohrvik

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7599759

5 June 2024

A. Furängen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7599759

5 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7599759

5 June 2024

publication date

1 March 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7599759%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

21 October 2019

http://www.tandfonline.com/doi/pdf/10.3109/08037059509077575

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

5 June 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7599759%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7599759%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7599759%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

85-90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7599759%20AND%20SRC:MED&resulttype=core&format=json

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

21 October 2019

cites work

3

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)

5 June 2024

4

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party

5 June 2024

5

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

The Captopril Prevention Project: a prospective intervention trial of angiotensin converting enzyme inhibition in the treatment of hypertension. The CAPPP Group

5 June 2024

6

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

STOP-Hypertension 2: a prospective intervention trial of "newer" versus "older" treatment alternatives in old patients with hypertension. Swedish Trial in Old Patients with Hypertension

5 June 2024

7

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

5 June 2024

9

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

Salt blocks the renal benefits of ramipril in diabetic hypertensive rats

5 June 2024

10

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

[Conversion enzyme inhibitors in the antihypertensive treatment of patients with renal insufficiency]

5 June 2024

12

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

Converting enzyme inhibition in chronic renal failure

5 June 2024

13

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

Renal protective effect of enalapril in diabetic nephropathy

5 June 2024

15

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

5 June 2024

16

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

Increased Glomerular Filtration Rate after Converting-Enzyme Inhibition in Essential Hypertension

5 June 2024

17

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-aldosterone system

5 June 2024

18

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate

5 June 2024

19

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

Association between blood pressure and the rate of decline in renal function with age

5 June 2024

20

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

Renal function as an indicator of prognosis in malignant essential hypertension

5 June 2024

21

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

A Simple Method for the Determination of Glomerular Filtration Rate

5 June 2024

22

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

Organization and efficacy of an out-patient hypertension clinic

5 June 2024

23

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

Malignant Hypertension-Improving Prognosis in a Rare Disease

5 June 2024

25

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

Initial effect of enalapril on kidney function in patients with moderate to severe chronic nephropathy

5 June 2024

28

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

??-Blockers and Renal Function

5 June 2024

30

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

Possible mechanism for the renoprotective effect of angiotensin converting enzyme inhibitors

5 June 2024

31

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point

5 June 2024

33

1 reference

https://api.crossref.org/works/10.3109/08037059509077575

5 June 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7599759%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference